Philips is conducting a study to test an ultralow-dose X-ray technique in a cath lab setting. The study, referred to as the RADIQAL trial, aims to reduce radiation exposure during coronary procedures, such as coronary angiography. The trial is part of Philips' efforts to develop and enhance its medical imaging technologies, including its Azurion platform and mobile C-arm platforms.